2002P-0025
REF 1
Volume 1

Reference List

Reference 1 - Statement of Karen Midthun, M.D., Director, Office of Vaccine Research and Review, CBER, FDA before the Committee on Government Reform, United States House of Representatives, December 10, 2002.

Reference 2 - Ball LK, Ball R, Pratt RD, An assessment of thimerosal use in childhood vaccines, Pediatrics 2001; 1147-1154. Published Material

Reference 3 - Thimerosal in Vaccines. U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Updated March 21, 2005. Available: http://www.fda.gov/cber/vaccine/thimerosal.htm

Reference 4 - Thimerosal-Containing Vaccines and Neurodevelopmental Disorders, Institute of Medicine (IOM), Washington, D.C.: National Academy Press; 2001. Published Material

Reference 5 - Immunization Safety Review: Vaccine and Autism, Institute of Medicine (IOM), (Executive Summary, at 4) (emphasis in original), Washington, D.C.: National Academy Press; 2004. Published Material

Reference 6 - Plotkin, Stanley A., et al, Vaccines, 4th Edition, 2004. Published Material

Reference 7 - Prevention and Control of Influenza: Recommendations and Reports, CDC’s Advisory Committee on Immunization Practices (ACIP), April 25, 2003. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5208a1.htm

Reference 8 Published Material